Table 1.
Clinical characteristics of the study participants
| All (n = 185) |
No sarcopenia (n = 57) |
Probable sarcopenia (n = 77) |
Sarcopenia (n = 51) |
p-value | |
|---|---|---|---|---|---|
| Age [Years] | 79.8 ± 6.1 | 76.8 ± 4.8 | 81.1 ± 6.0 | 81.3 ± 6.4 | < 0.001 |
| Women, n (%) | 141 (76.2) | 50 (87.7) | 64 (83.1) | 27 (52.9) | < 0.001* |
| BMI [kg/m2] | 25.8 ± 5.0 | 26.8 ± 4.6 | 27.6 ± 4.9 | 21.8 ± 3.1 | < 0.001 |
| MMSE [/30 points] | 27.0 ± 2.6 | 28.4 ± 2.0 | 27.5 ± 2.1 | 25.9 ± 3.0 | < 0.001 |
| BDI-II [/63 points] | 11.7 ± 7.8 | 12 ± 9.5 | 11.9 ± 7.1 | 11.1 ± 6.8 | 0.793 |
| CCI [points] | 1.9 ± 2.1 | 1.2 ± 1.5 | 1.7 ± 1.9 | 2.8 ± 2.6 | < 0.001 |
| Number of drugs | 7.7 ± 3.4 | 6.5 ± 2.9 | 7.9 ± 3.5 | 8.6 ± 3.4 | 0.004 |
| SF-MNA [/14 points] | 11.2 ± 2.8 | 12.5 ± 1.7 | 11.8 ± 2.4 | 8.7 ± 3.0 | < 0.001 |
| SMI [kg/m2] | 6.6 ± 1.2 | 6.9 ± 1.1 | 7.0 ± 1.0 | 5.5 ± 0.8 | < 0.001 |
| Hand grip strength [kg] | 22 ± 7.7 | 26.3 ± 6.8 | 21 ± 8.1 | 18.6 ± 5.7 | < 0.001 |
| Gait speed [m/s] | 0.82 ± 0.38 | 1.2 ± 0.44 | 0.72 ± 0.23 | 0.60 ± 0.23 | < 0.001 |